Big Average Payables from 2010 to 2026
| PRM Stock | CAD 14.03 -0.23 -1.61% |
Average Payables | First Reported 2010-12-31 | Previous Quarter 309.1 K | Current Value 274.7 K | Quarterly Volatility 18.2 K |
Macro event markers
Use the financial statements timeline for Big Pharma to frame performance drivers and balance sheet structure. This context pairs drivers like Depreciation And Amortization of 343.3 K, Interest Expense of 438.1 K or Selling General Administrative of 344.4 K and ratios such as Price To Sales Ratio of 8.82, Dividend Yield of 0.08 or PTB Ratio of 0.81 with Big Pharma Valuation and Volatility views.
Big | Average Payables |
Pair Trading with Big Pharma
Pair trading with Big Pharma can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Moving against Big Stock
Correlation matrices help investors optimize their Big Pharma tax-loss harvesting strategy by identifying the best available substitutes. The higher the correlation to Big Pharma Split, the less the portfolio's risk profile will shift during the wash-sale waiting period.
The pairwise correlation of Big Pharma measures the historical tendency for two assets to move in the same or opposite directions. High correlations between Big Pharma Split and another holding indicate concentrated risk that may amplify losses in adverse market conditions.
Use Correlation analysis and pair trading evaluation for Big Pharma to review hedging context. The method can be applied across sectors and broader equity sets.More Resources for Big Stock Analysis
Other Information on Investing in Big Stock
Financial ratios for Big Pharma help frame valuation context across profits, cash flow, and enterprise value. They help compare Big across valuation measures and peers.